SGK Reimbursement Policies Ire Turkish Devices Industry
This article was originally published in PharmAsia News
Executive Summary
The public reimbursement agency SGK’s new pricing policies for medical devices, launched in October, caused severe reactions from the industry, who complained that reimbursement limits for many products were cut back, rendering commercial import and production of these items very difficult.